Orthofix International N.V. (NASDAQ: OFIX) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its competitors? We will compare Orthofix International N.V. to related businesses based on the strength of its analyst recommendations, institutional ownership, risk, earnings, dividends, profitability and valuation.

Profitability

This table compares Orthofix International N.V. and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orthofix International N.V. 1.88% 9.96% 7.32%
Orthofix International N.V. Competitors -126.98% -36.36% -10.16%

Volatility and Risk

Orthofix International N.V. has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500. Comparatively, Orthofix International N.V.’s competitors have a beta of 1.06, suggesting that their average share price is 6% more volatile than the S&P 500.

Valuation and Earnings

This table compares Orthofix International N.V. and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Orthofix International N.V. $418.71 million $45.74 million 117.86
Orthofix International N.V. Competitors $827.23 million $159.50 million 36.91

Orthofix International N.V.’s competitors have higher revenue and earnings than Orthofix International N.V.. Orthofix International N.V. is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

96.2% of Orthofix International N.V. shares are owned by institutional investors. Comparatively, 65.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 5.6% of Orthofix International N.V. shares are owned by insiders. Comparatively, 11.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and target prices for Orthofix International N.V. and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix International N.V. 0 0 5 0 3.00
Orthofix International N.V. Competitors 174 1135 2485 89 2.64

Orthofix International N.V. presently has a consensus price target of $52.50, suggesting a potential upside of 6.06%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 8.09%. Given Orthofix International N.V.’s competitors higher probable upside, analysts plainly believe Orthofix International N.V. has less favorable growth aspects than its competitors.

Summary

Orthofix International N.V. beats its competitors on 7 of the 13 factors compared.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.